Allison Herman A
SR-AHEC Family Practice Clinic, Fayetteville, North Carolina.
Crit Care Nurs Q. 2019 Apr/Jun;42(2):165-172. doi: 10.1097/CNQ.0000000000000249.
Uncontrolled blood loss is a major cause of preventable death worldwide. A severe injury can occur anywhere at any time. Controlling blood loss is an important issue for patient care in the hospital setting. Through the casualties of war, the lifesaving value of quick interventions was developed. Since 2001, new hemostatic agents have advanced the benefits of controlling blood loss. There are unforgettable lessons learned in the preventable deaths of many soldiers and should be passed on to the next generation of health care providers, to include all hospitals up to level I trauma hospitals. This article covers the current hemostatic agents that have been used for more than 17 years on the battlefield and are slowly making their way into the hospital settings. The hemostatic agents covered include QuikClot Combat Gauze, QuikClot Control+, WoundClot Hemostatic Gauze, HemCon Nasal Plug, and RevMedx's XSTAT hemostatic device. The standard of care should not be affected by the location of a patient, whether that patient is in a remote village overseas, on the battlefield, a rural farm, or at a major metropolitan hospital here in the United States.
失控性失血是全球可预防死亡的主要原因。严重损伤可在任何时间、任何地点发生。控制失血是医院环境中患者护理的一个重要问题。通过战争伤亡情况,人们认识到了快速干预的救生价值。自2001年以来,新型止血剂提升了控制失血的效果。在许多士兵本可避免的死亡中,有令人难忘的教训,这些教训应传授给下一代医疗服务提供者,包括所有医院直至一级创伤医院。本文介绍了在战场上使用了17年以上且正逐渐进入医院环境的现有止血剂。所涵盖的止血剂包括快速凝血战斗纱布、快速凝血控制+、伤口凝血止血纱布、HemCon鼻塞以及RevMedx公司的XSTAT止血装置。护理标准不应受患者所在位置的影响,无论该患者是在海外偏远村庄、战场、乡村农场还是美国的大型都市医院。